Plasma proteomic profiles of patients with atopic dermatitis with moderate-to-severe pruritus treated with a single dose of nemolizumab

JID Innovations · Published 2026-02-10 · DOI 10.1016/j.xjidi.2026.100457

Free full text

Authors being retrieved — see the publisher record. https://doi.org/10.1016/j.xjidi.2026.100457

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Related articles

• High-salt diet aggravates skin inflammation of psoriasis-like mouse model with CCL20‒CCR6 axis further activation · JID Innovations · 2026 · Same journal
• Visualizing dermatology clinic routines using narrative networks · JID Innovations · 2026 · Same journal
• Autoantibodies as biomarkers of cancer risk in dermatomyositis · JID Innovations · 2026 · Same journal
• Development of a noninvasive device and method for measuring immune parameters in skin disease · JID Innovations · 2026 · Same journal
• Contribution of HMGB1 to keratinocyte inflammation in recessive dystrophic epidermolysis bullosa · JID Innovations · 2026 · Same journal
• Human keratinocytes exhibit limited potential for SARS-CoV-2 infection despite ACE2 and mature cathepsin L expression · JID Innovations · 2025 · Same journal
• A bioelectric dressing improves postderoofing outcomes in hidradenitis suppurativa by microbiome modulation: A split-body, randomized clinical trial · JID Innovations · 2026 · Same journal
• Local IgG autoantibody profiles in hidradenitis suppurativa and their associations with disease features and anti-TNF therapy · JID Innovations · 2026 · Same journal
• Spatial transcriptomic profiling reveals fibroblast and inflammatory signatures in calcinosis of chronic cutaneous lupus · JID Innovations · 2026 · Same journal
• CIT tumor lines: A series of immunogenic murine cutaneous squamous cell carcinoma cell lines derived from chemical carcinogenesis · JID Innovations · 2026 · Same journal